Vaxsafe® HVT
Vaxsafe® HVT is a high titred Marek's Type 3 live cell associated vaccine being produced by BIOPROPERTIES in Australia to control Marek's disease in broilers.
Vaxsafe® HVT induces immunity to Marek's disease and reduces the incidence of T-cell transformation.
Primarily mass applied via sub-cutaneous or in ovo injection, Vaxsafe® HVT was first registered in 1998.
Registration # 50538.
 Brochure (not yet available) |
Viewing of these files requires Adobe Reader. |
MSDS |
|
Product Leaflet |
|
Diluent MSDS |
